Palatin Technologies Stock Price, News & Analysis (NYSEAMERICAN:PTN)

$0.97 0.10 (11.49 %)
(As of 11/22/2017 07:58 AM ET)
Previous Close$0.87
Today's Range$0.91 - $1.00
52-Week Range$0.29 - $1.00
Volume5.71 million shs
Average Volume1.94 million shs
Market Capitalization$184.58 million
P/E RatioN/A
Dividend YieldN/A

About Palatin Technologies (NYSEAMERICAN:PTN)

Palatin Technologies logoPalatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. The Company's primary product in clinical development is bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder (HSDD), which is a type of female sexual dysfunction (FSD) defined as low desire with associated distress. Its other drug development programs include Melanocortin receptor-4 (MC4r), PL-3994 and Melanocortin receptor-1 (MC1r). MC4r is a compound used for treatment of obesity and diabetes. PL-3994 is a subcutaneously injected guanylate-cyclase type A (GC-A) receptor agonist. MC1r agonist peptides are used for treatment of inflammatory and dermatologic disease indications.

Industry, Sector and Symbol:
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Sector: Biotechnology & Medical Research - NEC
  • Previous Symbol: NYSE:PTN
  • CUSIP: N/A
  • Web:
  • Trailing EPS: $0.05
  • Net Margins: 39.28%
  • Return on Assets: 90.43%
  • Outstanding Shares: 190,310,000

Frequently Asked Questions for Palatin Technologies (NYSEAMERICAN:PTN)

What is Palatin Technologies' stock symbol?

Palatin Technologies trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "PTN."

How were Palatin Technologies' earnings last quarter?

Palatin Technologies, Inc. (NYSEAMERICAN:PTN) released its earnings results on Monday, November, 13th. The biopharmaceutical company reported $0.05 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.06 by $0.01. The biopharmaceutical company earned $26.94 million during the quarter, compared to analysts' expectations of $28 million. During the same period in the previous year, the business posted ($0.08) EPS. View Palatin Technologies' Earnings History.

Where is Palatin Technologies' stock going? Where will Palatin Technologies' stock price be in 2017?

2 brokerages have issued twelve-month target prices for Palatin Technologies' stock. Their predictions range from $2.00 to $6.00. On average, they anticipate Palatin Technologies' stock price to reach $4.00 in the next year. View Analyst Ratings for Palatin Technologies.

Are investors shorting Palatin Technologies?

Palatin Technologies saw a increase in short interest in October. As of October 31st, there was short interest totalling 3,249,926 shares, an increase of 7.5% from the October 13th total of 3,024,549 shares. Based on an average daily trading volume, of 1,304,756 shares, the short-interest ratio is currently 2.5 days. Approximately 1.9% of the shares of the stock are short sold.

Who are some of Palatin Technologies' key competitors?

Who are Palatin Technologies' key executives?

Palatin Technologies' management team includes the folowing people:

  • John K. A. Prendergast Ph.D., Chairman of the Board (Age 63)
  • Carl Spana Ph.D., President, Chief Executive Officer, Director (Age 53)
  • Stephen T. Wills CPA, Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary (Age 59)
  • Anthony M. Manning Ph.D., Director (Age 55)
  • Robert K. deVeer Jr., Independent Director (Age 70)
  • Alan William Dunton M.D., Independent Director (Age 61)
  • Zola P. Horovitz Ph.D., Independent Director (Age 80)
  • Joseph Stanley Hull, Independent Director (Age 64)

Who owns Palatin Technologies stock?

Palatin Technologies' stock is owned by many different of institutional and retail investors. Top institutional investors include Russell Investments Group Ltd. (0.13%) and Bank of New York Mellon Corp (0.08%). View Institutional Ownership Trends for Palatin Technologies.

Who bought Palatin Technologies stock? Who is buying Palatin Technologies stock?

Palatin Technologies' stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd. and Bank of New York Mellon Corp. View Insider Buying and Selling for Palatin Technologies.

How do I buy Palatin Technologies stock?

Shares of Palatin Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Palatin Technologies' stock price today?

One share of Palatin Technologies stock can currently be purchased for approximately $0.97.

How big of a company is Palatin Technologies?

Palatin Technologies has a market capitalization of $184.58 million.

How can I contact Palatin Technologies?

Palatin Technologies' mailing address is 4B Cedarbrook Dr, CRANBURY, NJ 08512-3641, United States. The biopharmaceutical company can be reached via phone at +1-609-4952200.

MarketBeat Community Rating for Palatin Technologies (NYSEAMERICAN PTN)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  168 (Vote Outperform)
Underperform Votes:  96 (Vote Underperform)
Total Votes:  264
MarketBeat's community ratings are surveys of what our community members think about Palatin Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Palatin Technologies (NYSEAMERICAN:PTN)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $4.00

Consensus Price Target History for Palatin Technologies (NYSEAMERICAN:PTN)

Price Target History for Palatin Technologies (NYSEAMERICAN:PTN)

Analysts' Ratings History for Palatin Technologies (NYSEAMERICAN:PTN)

DateFirmActionRatingPrice TargetDetails
11/13/2017Canaccord GenuitySet Price TargetBuy$6.00View Rating Details
10/29/2017Roth CapitalSet Price TargetBuy$2.00View Rating Details
9/22/2016S&P Equity ResearchLower Price Target$0.61 -> $0.55View Rating Details
(Data available from 11/22/2015 forward)


Earnings History and Estimates Chart for Palatin Technologies (NYSEAMERICAN:PTN)

Earnings by Quarter for Palatin Technologies (NYSEAMERICAN:PTN)

Earnings History by Quarter for Palatin Technologies (NYSEAMERICAN PTN)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/13/2017Q1 18$0.06$0.05$28.00 million$26.94 millionViewN/AView Earnings Details
9/25/2017Q4 17($0.02)$0.07$18.54 million$33.90 millionViewN/AView Earnings Details
5/18/2017Q3 2017$0.10($0.02)$60.00 million$10.82 millionViewN/AView Earnings Details
2/9/2017Q2 2017($0.07)($0.06)ViewListenView Earnings Details
11/15/2016Q117($0.08)($0.08)ViewN/AView Earnings Details
9/20/2016Q416($0.08)($0.09)ViewListenView Earnings Details
5/17/2016Q316($0.08)($0.08)ViewN/AView Earnings Details
2/16/2016Q216($0.07)($0.08)ViewN/AView Earnings Details
11/12/2015Q116($0.08)($0.08)ViewListenView Earnings Details
9/21/2015Q415($0.06)($0.09)$2.05 million$12.95 millionViewListenView Earnings Details
5/13/2015Q315($0.04)($0.07)$0.41 millionViewListenView Earnings Details
2/13/2015Q115$0.01$0.03$5.40 million$4.90 millionViewN/AView Earnings Details
11/18/2014Q1 15$0.04$0.01$9.00 million$4.93 millionViewN/AView Earnings Details
9/9/2014Q4 14$0.03($0.04)ViewN/AView Earnings Details
5/13/2014Q3($0.03)($0.01)$500.00 millionViewListenView Earnings Details
11/14/2013Q1($0.05)($0.04)ViewListenView Earnings Details
10/1/2013Q413($0.05)($0.04)ViewListenView Earnings Details
5/14/2013Q3 2013($0.05)($0.04)$0.02 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Palatin Technologies (NYSEAMERICAN:PTN)

No earnings estimates for this company have been tracked by


Dividend History for Palatin Technologies (NYSEAMERICAN:PTN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Palatin Technologies (NYSEAMERICAN PTN)

Insider Trades by Quarter for Palatin Technologies (NYSEAMERICAN:PTN)
Institutional Ownership by Quarter for Palatin Technologies (NYSEAMERICAN:PTN)

Insider Trades by Quarter for Palatin Technologies (NYSEAMERICAN PTN)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/4/2015Joseph Stanley HullDirectorBuy2,500$0.66$1,650.00View SEC Filing  
10/2/2015Robert K Deveer JrDirectorBuy10,000$0.82$8,200.00View SEC Filing  
2/26/2014Bvf Partners L P/IlMajor ShareholderSell540,181$1.14$615,806.34View SEC Filing  
2/19/2014Bvf Partners L P/IlMajor ShareholderSell305,966$1.17$357,980.22View SEC Filing  
3/19/2013Alan W DuntonDirectorBuy1,000$0.58$580.00View SEC Filing  
2/1/2013Alan W DuntonDirectorBuy2,000$0.59$1,180.00View SEC Filing  
1/28/2013Robert I TaberDirectorBuy5,000$0.59$2,950.00View SEC Filing  
12/31/2012Carl SpanaCEOBuy10,000$0.57$5,700.00View SEC Filing  
12/28/2012Stephen T WillsCFOBuy10,000$0.56$5,600.00View SEC Filing  
12/24/2012Perry B MolinoffDirectorBuy10,000$0.61$6,100.00View SEC Filing  
12/14/2012Robert K Deveer JrDirectorBuy21,960$0.70$15,372.00View SEC Filing  
9/4/2012Alan W DuntonDirectorBuy1,000$0.58$580.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Palatin Technologies (NYSEAMERICAN PTN)

No headlines for this company have been tracked by

Social Media

Social activity is not available for this stock.



Palatin Technologies (NYSEAMERICAN PTN) Chart for Wednesday, November, 22, 2017
Loading chart…

This page was last updated on 11/22/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.